Reuters logo
BRIEF-Targovax starts first clinical trial with TG02
April 20, 2017 / 6:40 AM / 6 months ago

BRIEF-Targovax starts first clinical trial with TG02

April 20 (Reuters) - TARGOVAX ASA:

* INITIATES FIRST CLINICAL TRIAL WITH TG02, THE SECOND PRODUCT FROM ITS RAS-PEPTIDE IMMUNOTHERAPY PLATFORM Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below